Remove 2001 Remove Communication Remove Packaging
article thumbnail

IGI and AbbVie sign licence deal for cancer and autoimmune therapy

Pharmaceutical Technology

July 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook AbbVie will gain exclusive rights to develop, manufacture and market ISB 2001 across several major regions. Our partnership with AbbVie accelerates ISB 2001’s path to patients and sharpens our focus on advancing the next generation of BEAT-enabled assets in oncology.”

article thumbnail

UK steps up with £1.25bn Gavi vaccine pledge as US funding disappears

Pharmaceutical Technology

I call on Gavi today to re-earn the public trust and to justify the $8bn that America has provided in funding since 2001,” he said in a video statement. In a move that reflects the country’s ongoing pullback from international aid , US health secretary Robert F Kennedy, Jr (RFK) claimed Gavi had ignored science. “I

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Regulating decentralised manufacturing in the UK – a legal perspective

European Pharmaceutical Review

In the EU, the EU pharmaceutical package of reform 5 includes a proposed new Directive, 6 which will replace the current Medicines Directive (2001/83/EC). Technology For the technical operation of a web of sites, systems must enable them to all share data and communicate with each other. Internet] UK Government.

article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

7 Access to digital communications also remains a challenge in some Member States especially for those groups at risk of poverty and social exclusion (7.6 Even in countries with high smartphone usage such as Denmark, up to 25 percent of the population do not possess a smartphone. References European Commission, (26 April 2023).

article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

It is too early to say because we have not seen the whole package of measures yet. COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS Pharmaceutical Strategy for Europe. References. European Commission. Brussels; 2020.

article thumbnail

The Important Role that Biopharmaceutics Plays in Accelerating Early-Phase Drug Development

Pharmaceutical Technology

Quotient Sciences supported a standalone DCS classification and formulation development package. S54 – S61 (2001). A recent example of this was for a compound at the candidate selection stage. However, solubility at 3 hours was found to be >10-fold higher and hence it was classified as a DCS IIa compound. Grass and P.